Poster Session I - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P480 - ESOC25-1882 CIRCULATING LNCRNAS AS POTENTIAL BIOMARKERS OF HAEMATOMA GROWTH IN INTRACEREBRAL HAEMORRHAGE: A PILOT STUDY Maria Lucas-Parra 1 , Carme Gubern-Mrida 1 , Carla Herminia Vera Caceres 2 , Dolors Puigoriol Illamola 1 , Laia Carballo-Perich 1 , Mikel Terceo 3 , Saima Bashir Viturro 1,2 , Toms Xucl-Ferrarons 1,2 , Vctor Vera-Monge 2 , Alan Murillo 2 , Juan Alvarez-Cienfuegos 1,2 , Isabel Vielba 2 , Elisabet Ortiz Martos 2 , Joaquin Serena 1,2 , Yolanda Silva 1,2 1 Institut dInvestigaci Biomdica de Girona (IDIBGI), Cerebrovascular Pathology group, Salt, Spain, 2 Hospital Universitari Dr
No formal FDA rule had been published as of that date
Annual thyroid function testing may be prudent given theoretical thyroid concerns, though risk appears minimal in humans
It has been shown along with the triglyceride tributyrin to regulate cytokine levels, eliciting strong anti-inflammatory effects
